Insider selling
Traded Dec 3, 2024 · filed 3 days laterNot reported under a pre-arranged trading plan
Rythm's Chief Science Officer sold $43K of Rythm shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 22, 2024 · Filed Nov 25, 2024
The CEO of Rythm paid $229K out of pocket for Rythm shares. It was the first purchase in over a year. Shares held went up 50% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$229,472
Shares × reported transaction price
$100K–$500K
Benjamin Kovler, Interim CEO's past purchases, 90 days after disclosure: 4 buys, median −46.5 pts vs S&P 500, beat it 0 of 4 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
+50.0%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 13 months of history
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
8 days after results of Nov 14, 2024, 119 days before results of Mar 21, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider selling
Traded Dec 3, 2024 · filed 3 days laterNot reported under a pre-arranged trading plan
Rythm's Chief Science Officer sold $43K of Rythm shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Dec 3, 2024 · filed 3 days laterNot reported under a pre-arranged trading plan
Rythm's Chief Science Officer sold $102K of Rythm shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Dec 3, 2024 · filed 3 days laterNot reported under a pre-arranged trading plan
Rythm's Chief Science Officer sold $47K of Rythm shares. The filing does not indicate a pre-arranged trading plan.